Clinical Trials
4 trialsNCT00472303 2019-11-04
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Completed
NCT01264887 2019-11-04
Tapentadol in Chronic Malignant Tumour Related Pain
Grünenthal GmbH
Phase 3 Terminated
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT00805142 2013-07-29
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
Janssen Pharmaceutical K.K.
Phase 2 Completed